Brian Booth to Cell Line, Tumor
This is a "connection" page, showing publications Brian Booth has written about Cell Line, Tumor.
Connection Strength
0.721
-
The in vivo biocompatibility of novel tannic acid-collagen type I injectable bead scaffold material for breast reconstruction post-lumpectomy. J Biomater Appl. 2020 04; 34(9):1315-1329.
Score: 0.121
-
Amphiregulin regulates proliferation and migration of HER2-positive breast cancer cells. Cell Oncol (Dordr). 2018 Apr; 41(2):159-168.
Score: 0.105
-
HER2+ breast cancer cells undergo apoptosis upon exposure to tannic acid released from remodeled cross-linked collagen type I. J Biomed Mater Res A. 2018 Jan; 106(1):26-32.
Score: 0.104
-
Cancer cell redirection biomarker discovery using a mutual information approach. PLoS One. 2017; 12(6):e0179265.
Score: 0.101
-
RNA Expression Profiling Reveals Differentially Regulated Growth Factor and Receptor Expression in Redirected Cancer Cells. Stem Cells Dev. 2017 05 01; 26(9):646-655.
Score: 0.099
-
Validation of an in vitro model of erbB2(+) cancer cell redirection. In Vitro Cell Dev Biol Anim. 2015 Sep; 51(8):776-86.
Score: 0.088
-
Remodeling of tannic acid crosslinked collagen type I induces apoptosis in ER+ breast cancer cells. Anticancer Res. 2015 Mar; 35(3):1285-90.
Score: 0.087
-
Reprogramming human cancer cells in the mouse mammary gland. Cancer Res. 2010 Aug 01; 70(15):6336-43.
Score: 0.016